Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Two-Year Prospective Study of Antibody Response and Longevity Post SARS-CoV-2 Vaccine and Their Correlation With Humoral Factors

NCT05515081 is registered in ClinicalTrials.gov with IRCCS San Camillo, Venezia, Italy as lead sponsor.

NCT NCT05515081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05515081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Two-Year Prospective Study of Antibody Response and Longevity Post SARS-CoV-2 Vaccine and Their Correlation With Humoral Factors
Lead sponsor
IRCCS San Camillo, Venezia, Italy
Phase
Not applicable
Overall status
Completed
Start date
May 21, 2021
Completion date
May 21, 2023
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vaccine reaction